We report a very rare case of severe pulmonary arterial hypertension in a patient with neurofibromatosis type 1, and discuss the pathology, pathogenesis, current pulmonary hypertension classification system, and outcomes of pulmonary arterial hypertension in patients with neurofibromatosis type 1.
ReynoldsRM, BrowningGG, NawrozI, CampbellIW. Von Recklinhausen's neurofibromatosis: neurofibromatosis type 1. Lancet, 2003; 361(9368):1552–1554.
2.
ZamoraAC, CollardHR, WoltersPJ, WebbWR, KingTE. Neurofibromatosis-associated lung disease: a case series and literature review. Eur Respir J, 2007; 29(1):210–214.
3.
SimonneauG, RobbinsI, BeghettiM, ChannickRN, DelcroixM, DentonCP, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol, 2009; 54(Suppl 1):S43–S54.
4.
GalieN, HoeperMM, HumbertMJC, TorbickiA, VachieryJ-L, BarberaJAet al; The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology and the European Respiratory Society, endorsed by the International Society of Heart and Lung Transplantation. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J, 2009; 30(20):2493–2537.
5.
PorterfieldJK, PyeritzRE, TraillTA. Brief clinical report: pulmonary hypertension and interstitial fibrosis in von Recklinghausen neurofibromatosis. Am J Med Genet, 1986; 25(3):531–535.
6.
SamuelsN, BerkmanN, MilgalterE, Bar-ZivJ, AmirG, KramerM. Pulmonary hypertension secondary to neurofibromatosis: intimal fibrosis versus thromboembolism. Thorax, 1999; 54(9):858–859.
7.
AokiY, KodamaM, MezakiT, OgawaR, SatoM, OkabeM, et al. Von Recklinghausen disease complicated by pulmonary hypertension. Chest, 2001; 119(5):1606–1608.
8.
HernandezFJG, RonanJS, MedinaCO, RomeroLM. [Hipertension arterial pulmonary primaria en un paciente con neurofibromatosis]. Med Clin (Barc), 2002; 118(2):78–79. Article in Spanish.
9.
SimenoniS, PuccettiA, ChilosiM, TinazziE, PratiD, CorrocherR, et al. Type 1 neurofibromatosis complicated by pulmonary artery hypertension: a case report. J Med Invest, 2007; 54(3-4):354–358.
10.
EngelPJ, BaughmanRP, MenonSG, KereiakesDJ, TaylorL, ScottM. Pulmonary hypertension in neurofibromatosis. Am J Cardiol, 2007; 99(8):1177–1178.
11.
StewartDR, CoganJD, KramerMR, MillerWT, ChristiansenLE, PauciuloMW, et al. Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy?. Chest, 2007; 132(3):798–808.
12.
HamiltonSJ, FriedmanJM. Insights into the pathogenesis of neurofibromatosis 1 vasculopathy. Clin Genet, 2000; 58(5):341–344.
13.
McLaughlinVV, ArcherSL, BadeschDB, BarstRJ, FarberHW, LinderJR, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society; and the Pulmonary Hypertension Association. J Am Coll Cardiol, 2009; 53(17):1573–1619.
14.
RosenfeldA, ListernickR, CharriwJ, GoldmanS. Neurofibromatosis type 1 and high-grade tumors of the central nervous system. Childs Nerv Syst, 2010; 26(5):663–667.
15.
SinghalS, BirchJM, KerrB, LashfordL, EvansDGR. Neurofibromatosis type 1 and sporadic optic gliomas. Arch Dis Child, 2002; 87(1):65–70.
16.
MerloCA, StuderSM, ConteJV, YangSC, SonnettJ, OrensJB. The course of neurofibromatosis type 1 on immunosuppression after lung transplantation: report of 2 cases. J Heart Lung Transplant, 2004; 23(6):774–776.
